TPOXX® (tecovirimat) – New drug approval
July 13, 2018 - The FDA announced the approval of SIGA Technologies’ TPOXX (tecovirimat), for the treatment of human smallpox disease caused by variola virus in adults and pediatric patients weighing at least 13 kg.
Download PDF
